“A nutraceutical company runs on the wheels of innate energy fortified with the strength of courage and the ability to recognize that everything is possible”.

Sitagliptin is an oral antihyperglycemic antidiabetic drug of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its fewer side effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. While safety is its advantage, efficacy is often challenged as it is often recommended to be combined with other agents like metformin. Exenatide (Byetta) also works by its effect on the incretin system.

 

Please contact marketing@nutraforlife.com to get a copy of the latest Certificate of Analysis

 

Legal Note

Product exploitation, including development, sales and offer for sale are performed where permissible by patent law. This presentation is not and should not constitute an offer for sale in territories where it is not permitted by law. In USA Products that are Currently on Patent are available for R&D Use in Accordance with 35 USC §271 (e) (1). The Buyer is fully responsible for any legal action.